Abiomed (ABMD) Tops Q1 EPS by 40c, Raises Lower End Of FY 2017 Guidance By $5M
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Investment income (expense), net: 342K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Investment income (expense), net: 342K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q1 EPS of $0.82, $0.40 better than the analyst estimate of $0.42. Revenue for the quarter came in at $132.5 million versus the consensus estimate of $130.89 million.
GUIDANCE:
Abiomed sees FY2018 revenue of $560-575 million, versus the consensus of $570.4 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
